• ALEX study is the first global phase III study to show a clinically meaningful benefit in overall survival at five years (62.5% with Alecensa), compared with crizotinib (45.5%) • Data confirm longer-term efficacy of Alecensa, both in patients with or without central nervous system metastases at baseline Roche (SIX: RO, ROG; OTCQX: RHHBY) on […]
Europe 2020 employment indicators 17 Member States achieved their 2020 targets In 2019, the year before COVID-19 containment measures were widely introduced by EU Member States, the employment rate of people aged 20 to 64 in the European Union of 27 Member States (EU) stood at 73.1%, up compared with 2018 (72.4%). The Europe 2020 […]
The aging population and the strong impact on residences are the main causes of the deadly incidence of the coronavirus, according to experts Spain began the fourth week of isolation on Monday as the country that has suffered the most deaths from the coronavirus in relation to its population. With 13,055 deaths, 28 per 100,000 […]
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Korean
Portuguese
Russian
Spanish